Intervention for HIV/AIDS
This trial aims to improve HIV treatment adherence among 18-29 year olds through automated directly observed therapy with incentives. Feasibility and acceptability are being assessed.
- Young Adults
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is the eligibility criterion for this experiment inclusive of elderly individuals?
"This medical research is looking for volunteers aged between 18 years and 29 years."
What is the upper limit of participants for this research endeavor?
"Affirmative. Clinicaltrials.gov affirms that this clinical experiment, initially posted on January 31st 2023, is actively enrolling patients. The study requires 30 volunteers to be recruited from a single medical facility."
Are there currently any slots available for participants of this medical trial?
"Clinicaltrials.gov confirms that this investigation is still actively recruiting participants, having first been announced on the 31st of January 2023 and then updated most recently on 16th March 2021."
What is the ultimate objective of this experiment?
"According to the trial sponsor, AiCure, this study's primary aim is to assess mean logins per week over 3 months. In addition, secondary objectives are being measured including self-reported ART adherence from a survey and mobile app data collected by AiCure platform tracking user behaviour (minutes in app) as well as ease of use via 7-point Likert scale responses."
Under what conditions is participation in this research trial open?
"This clinical trial's consideration criteria involves HIV/AIDS and an age range of 18 to 29. The enrollment process is aiming for approximately 30 patients."